PRESS RELEASE
News
-
-
PRESS RELEASE
Original-Research: LION E-Mobility AG (von NuWays AG): BUY
LION E-Mobility AG has announced the appointment of Dr. Joachim Damasky as the successor to the outgoing CEO, Winfried Buss. Dr. Damasky's extensive experience, including senior advisory roles at BMW and leadership positions at the German Automotive Association and Webasto, positions the company for strong growth. With the company's increased salesforce and partnerships with SVOLT for higher energy density battery packs, LION E-Mobility is poised to capitalize on the energy storage market and experience significant sales growth in the short to mid-term. The company's valuation remains attractive, and it is recommended as a BUY with a price target of €10.50 based on DCF. -
PRESS RELEASE
GANÉ Aktiengesellschaft: Dr Uwe Rathausky and J. Henrik Muhle named Fund Manager of the Year 2024
GANÉ Aktiengesellschaft's Directors and Fund Advisors, Dr Uwe Rathausky and J. Henrik Muhle, have been honored with the 'Fund Manager of the Year 2024' award by Finanzen Verlag for their exceptional performance. The award recognizes their successful management of the GANÉ Global Equity Fund and ACATIS GANÉ Value Event Fund, underpinned by their unique value and event investment strategy. This achievement reflects their dedication to delivering excellent results for investors and their commitment to long-term success in the market. For more information, visit www.gane.de. -
PRESS RELEASE
ANDRITZ holds Capital Markets Day on January 24
ANDRITZ, an international technology group, will hold its 2024 Capital Markets Day on January 24 in Leipzig, Germany. The event will provide updates on the group’s businesses, markets, strategy, and growth drivers, and will be available on the group’s website. ANDRITZ offers innovative solutions for various industries and end markets and aims to contribute to a sustainable future. With a global presence and a focus on long-term profitable growth, ANDRITZ is a market leader in Pulp & Paper, Metals, Hydropower, and Environment & Energy. -
PRESS RELEASE
Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months
Abivax, a clinical-stage biotechnology company, provides its 2024 strategic outlook and key milestones, including the expected data read-outs and trial results for its lead drug candidate obefazimod in the treatment of ulcerative colitis and Crohn’s disease. The company also outlines its financial update and objectives for strengthening its product pipeline. Learn more about Abivax's priorities and milestones for 2024. -
PRESS RELEASE
Abivax: Perspectives stratégiques d’Abivax pour 2024 et principales étapes au cours des 12 prochains mois
Abivax annonce ses perspectives stratégiques pour 2024 et les principales étapes des 12 prochains mois, y compris la publication des premiers résultats des essais d'induction du programme pivot ABTECT de phase 3 -
PRESS RELEASE
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc announced the purchase of 105,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange, as part of its share buyback program. The repurchased shares will be cancelled, and the company's total number of ordinary shares after settlement and cancellation will be 653,285,633. The detailed breakdown of individual trades made as part of the share buyback program is also provided in the announcement. -
PRESS RELEASE
Custodian Property Income REIT plc: Custodian Property Income REIT sells industrial unit at 9.5% premium to valuation
Custodian Property Income REIT plc (CREI) announces the sale of an industrial unit in Milton Keynes at a 9.5% premium to valuation, representing a significant profit for shareholders. The sale proceeds will be used to reduce the company's existing debt facility and fund future portfolio improvements. -
PRESS RELEASE
Update on the Scheme and Resignation of Directors
Arix Bioscience PLC provides an update on the recommended all-share acquisition of Arix's assets by RTW Biotech Opportunities Ltd, including the resignation of directors Maureen O'Connell and Isaac Kohlberg. The Scheme's condition related to the Share Purchase has been satisfied, and Arix expects to publish the Shareholder circular later this week. -
PRESS RELEASE
Nordea Bank Abp: Repurchase of own shares on 19.01.2024
Nordea Bank Abp has completed the repurchase of its own shares on 19.01.2024 as part of a share buy-back program. The transactions were executed in public trading and in accordance with relevant regulations. After the disclosed transactions, Nordea holds treasury shares for capital optimisation and remuneration purposes. For further information, investors and media can contact the provided representatives.
